Cargando…
Phenotypic alterations in breast cancer cells overexpressing the nuclear receptor co-activator AIB1
BACKGROUND: Estrogen signaling plays a critical role in a number of normal physiological processes and has important implications in the treatment of breast cancer. The p160 nuclear receptor coactivator, AIB1 (amplified in breast cancer 1), is frequently amplified and overexpressed in human breast c...
Autores principales: | Anzick, Sarah L, Azorsa, David O, Simons, S Stoney, Meltzer, Paul S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC201023/ https://www.ncbi.nlm.nih.gov/pubmed/12964942 http://dx.doi.org/10.1186/1471-2407-3-22 |
Ejemplares similares
-
Polymorphic repeat in AIB1 does not alter breast cancer risk
por: Haiman, Christopher A, et al.
Publicado: (2000) -
Oestrogen receptor co-activator AIB1 is a marker of tamoxifen benefit in postmenopausal breast cancer
por: Weiner, M., et al.
Publicado: (2013) -
Mechanism of 3‐Methylglutaconyl CoA Decarboxylase AibA/AibB: Pericyclic Reaction versus Direct Decarboxylation
por: Sheng, Xiang, et al.
Publicado: (2020) -
The AIBE and the new phase of the RBHH
por: Maiolino, Ângelo
Publicado: (2011) -
Expression of AIB1 protein as a prognostic factor in breast cancer
por: Lee, Kyungji, et al.
Publicado: (2011)